Delivery Order SPE2DB20D3101-SPE2DB23FRBL6
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $2,804.52 firm fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The award has an ultimate completion date of December 4, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $10,641.41 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of August 24, 2023. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $17,584.21 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,850.41 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of February 5, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $2,348.79. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,438.93 firm fixed price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $2,465.19 for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 24, 2022, with a performance completion date of May 25, 2022. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order valued at $12,432.70 for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The award has a completion date of February 23, 2024 and uses a firm fixed price pricing type. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The $5,456.23 firm fixed-price delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FRBL6Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Cencora, Inc. The $4,058.78 Firm Fixed Price Delivery Order is for the drug Trelegy Ellipta 100-62.5-25 60s. The award has an ultimate completion date of February 1, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These contract vehicles enable the efficient government procurement of essential pharmaceutical and medical commodities to serve the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract award was made through full and open competition with no set-aside designation, reflecting Amerisourcebergen's strong market position in pharmaceutical distribution to federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 1/31/23 |